雨課堂學(xué)堂在線學(xué)堂云《Biopharmaceutical and Toxicological Analysis(中國藥科)》單元測(cè)試考核答案_第1頁
雨課堂學(xué)堂在線學(xué)堂云《Biopharmaceutical and Toxicological Analysis(中國藥科)》單元測(cè)試考核答案_第2頁
雨課堂學(xué)堂在線學(xué)堂云《Biopharmaceutical and Toxicological Analysis(中國藥科)》單元測(cè)試考核答案_第3頁
雨課堂學(xué)堂在線學(xué)堂云《Biopharmaceutical and Toxicological Analysis(中國藥科)》單元測(cè)試考核答案_第4頁
雨課堂學(xué)堂在線學(xué)堂云《Biopharmaceutical and Toxicological Analysis(中國藥科)》單元測(cè)試考核答案_第5頁
已閱讀5頁,還剩9頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

第1題Whichoneisnotclassifiedasvolatilepoison?ACyanideBParaquatCFormaldehydeDPhenol第2題Aconitumandbelladonnaaregaseouspoisons.第3題Inordertoensuretheefficacyandsafetyofdrugs,theresearchobjectofbioanalysisshouldonlyfocusonthehumanbody.第4題Whichoneisnotclassifiedastheanimalpoison?ACantharidinBTetrodotoxinCAconitumDToadtoxin第5題ThetaskofbiopharmaceuticalandtoxicologicalanalysisdoesnotincludeAPerformanalyticalmethodologystudyBProvidedataforpharmacokineticresearchCProvidedataforclinicaltherapeuticdrugmonitoringDFindandsolvequalityproblemsintheproductionprocessofdrugpreparations第6題Poisonisachemicalthatcandamagethenormalactivitiesoflifethroughphysicochemicalactionafterenteringtheorganism,causingdiseasesorevendeath.第7題AccordingtoArticle357oftheCriminalLawofthePeople'sRepublicofChina,drugsaretheaddictivenarcoticandpsychotropicdrugsthatcancauseaddiction.第1題TheprocessbywhichthedrugentersthebloodcirculatorysystemfromthesiteofadministrationwithoutchemicalstructuralchangeiscalledAAbsorptionBDistributionCBiotransformationDExcretion第2題Whichdosageformhasthefastestabsorptionrate?ACapsuleBTabletCSustained-releasetabletDSolution第3題Theeffectofadrugisdirectlyrelatedtothetotalconcentrationofthedrugatthereceptorsite.Boththefreedrugandtheplasma-proteinbounddrugcanreachthereceptorsiteandshowthepharmacologicaleffect.第4題Duetothelargeabsorptionareaofthegastricmucosasurfaceandthelongerretentiontimeinthestomach,mostdrugsaremainlyabsorbedthroughthestomach.第5題Whenadrugenterstheliverthroughtheintestineforthefirsttime,somedrugscanbemetabolizedbyintestinaljuiceorenterobacteriaenzymesontheintestinalwall,ordrugenzymesintheliver,thusreducingtheamountofdrugenteringthesystemiccirculation.Thiseffectiscalledfirstpasseffect.第6題Whenthepermeabilityoftissuebiomembranedoesnothaveabarriereffect,whichfactorwillberate-limitingforthedrugdistribution?ApKaofthedrugBTissuebloodperfusionrateCDissociationdegreeatphysiologicalpHDPlasmaprotein-binding

第7題Amongthefollowingstatementsaboutactivetrasport,whichoneiswrong?AThedrugcanbetransportedagainstelectrochemicalgradientandconcentrationgradient.BRequiretheinvolvementofdrugtransporters.CNoneedtoconsumeenergy.DHasahighdegreeofselectivityandcanbecompetitivelyinhibitedbysimilarsubstances.第8題Whereisthedrugmetabolismmainlycarriedout?ALiverBGastrointestinaltractCSkinDKidney第9題WhichonedoesnotbelongtothephaseIreaction?AOxidationBReductionCHydrolysisDGlucuronidation第10題Whenanewdrug(itisasubstrateofCYP3A4)istakenwiththegrapefruitjuiceatthesametime,drug-druginteractionmayoccur.Whichstatementiswrong?AArepresentsthenewdrugwhichistakenalone.BArepresentsthenewdrugwhichistakentogetherwithgrapefruitjuice.CGrapefruitjuiceisamoderateinhibitorofCYP3A4.DInhibitorsofthemetabolicenzymescanslowdownthemetabolismofthesubstratedrugs.第11題CYP450isakindofmixed-functionoxidasesystemmainlyfoundinhumanliver.Becauseitcancombinewithcarbonmonoxideinthereducedstateandhasamaximumabsorptionpeakat450nmwavelength,itiscalledcytochromeP450.第12題Afterasingleoraldoseof25mgofethylmorphine,theaverageplasmaconcentrationofethylmorphineintheweakmetabolizer(PM)groupwassignificantlylowerthanthatinthestrongmetabolizer(EM)group.Asaresult,thepharmacologicaleffectswereweakened.第13題Amongthefollowingfactors,whichonecannotdirectlyaffecttheformationofthereceptor-drugcomplex(RD)?ADrugconcentrationatthereceptorsite.BNumberofreceptorsperunitvolume.CTheaffinitybetweenthedrugandthereceptor.DpKaofthedrug.

第14題Whichpharmacokineticparametercouldrepresentthetotaldrugamountabsorbedbythebody?APeakconcentration(Cmax)BAreaunderconcentration-timecurve(AUC)CPeaktime(Tmax)DApparentvolumeofdistribution(Vd)第15題Inordertoensuretheeffectivenessandsafetyoftheclinicaluseofdrugs,therapeuticdrugmonitoringshouldbecarriedoutaslongasthepatient'sfinancialabilitypermits.

Assignment第1題Amongthefollowingbiosamples,whichoneiscommonlyusedinthedeterminationofdrugmetabolitesinthebody?ABloodBUrineCMuscleDSaliva第2題DeterminationofdrugconcentrationinurineshoulduseAAny-timedurineBMorningurineCUrineduringthedayDTimedurine第3題Mostdrugsproducesystemictherapeuticeffectsafterenteringthebloodcirculation.Thereisacertainproportionalrelationshipbetweenthedrugconcentrationatthesiteofactionandthedrugconcentrationintheblood.Therefore,theclinicaltherapeuticeffectofthedrugpreparationcanbeindirectlypredictedbymeasuringthedrugconcentrationintheblood.第4題ThefalsestatementisAThemostcommonlyusedanticoagulantinplasmapreparationisheparin.BThedrughardlybindstofibrin,sothedrugconcentrationinplasmaandserumisusuallythesame.CSincetheamountofplasmaproducedislessthanthatofserum,mostresearchersprefertouseserumsamples.DSerumsamplesshouldbeusedwhenanticoagulantscontainedinplasmainterferewithdrugdetermination.第5題Plasmaorserumshouldbeseparatedintimeafterbloodcollection,generallynotmorethan2hours,andthenstoredinarefrigeratororfreezerafterseparation.Inordertoreduceoperationstepsandavoiderrors,itshouldnotpackedintosmallvolumes.第6題Useliquid-liquidextractionmethodtoextractacertainbasicdruginthetissuesample.Iftherearestillfat-solubleinterferingsubstancesintheextract,theextracteddrug-containingorganicphasecanbeback-extractedwithasmallvolumeofaqueoussolution,whichshouldbe

AAlkalineBNeutralCAcidicDAnypHisOK.第7題Useliquid-liquidextractionmethodtoextractacertainalkalinedrugwithpKa7.8inurine.WhatpHoftheurinesamplesshouldbeadjustedto?A5.8B7.8orlessC4.8orlessD10.8orabove10.8第8題10%trichloroaceticacidor6%perchloricacidsolutioncanbeusedtoprecipitateproteins,butthesupernatantisstronglyacidic(pH≤4),andthusisnotsuitablefordrugsapttodecomposeunderacidicconditions.第9題Biologicalsamplesshouldbeextractedunderacidicconditionstoreducetheinterferenceofendogenoussubstances(mostlyacidic)inthebiologicalmatrix.第10題Whichmethodcouldbeusedtodeterminethefreeaspirinconcentrationinplasma?AProteinprecipitationmethodBLiquid-liquidextractionCUltrafiltrationDSolidphaseextraction第11題TheproductformedbythecombinationofadrugoritsphaseImetaboliteswithendogenoussubstancesinthebodyiscalledphaseIImetabolitesorconjugates.Commonendogenoussubstancesareglucuronicacid,sulfuricacid,glycine,glutathioneandaceticacid.第12題ThemainpurposeofthechemicalderivatizationmethodinHPLCis:①ImprovethesensitivityofHPLCdetection;②Improvethevolatilityofdrugs.Themainderivatizationreactionsincludesilanization,esterification,acylation,andhalogenationderivatization,amongwhichsilanizationisthemostwidelyused.第13題Todeterminethetotalbloodconcentrationofwater-solubledrugs,whichmethodshouldbeused?ASolidphaseextractionBEnzymatichydrolysisCLiquid-liquidextractionDUltrafiltrationAssignment第1題Whenmeasuringbloodsamplesandtissues,alargeamountofproteinshouldberemovedfirst,andthedrugshouldbereleasedfromtheprotein-boundstate.第2題Whendeterminingsampleswithlowdrugconcentrations,itisadvisabletousetheextraction-concentrationmodeandhighlysensitiveanalyticaltechniques,suchasUVspectormetry.第3題Whatkindofpretreatmentmethodisnotsuitableforthestronglypolarorhydrophilicdrugs?ALiquid-liquidextractionBProteinprecipitationbyorganicsolventCProteinprecipitationbystrongacidDSolidphaseextraction第4題ThepreferredmethodfortheanalysisofsmallmoleculesinbiosamplesisAImmunoassayBHPLC-MSCBiologicalmethodDSpectroscopy第5題Whichonedoesnotbelongtothevalidationofbioanalyticalmethod.AStandardcurve

BAccuracyandprecisionCStabilityDForceddegradation第6題Whichitemcouldprovethatthesubstancemeasuredbytheproposedmethodistheexpectedanalyte.AStandardcurveandquantitativerangeBMatrixeffectCStabilityDSpecificity第7題Forthebioanalyticalmethod,thestandardcurveoflinearmodeshouldcontainatleast5concentrationpointsinadditiontothezeropoint.第8題Inthestudyofpharmacokineticsandbioavailability,LLOQshouldbeabletodeterminethedrugconcentrationinbiosamplesat3-5eliminationhalf-livesafterdosingorwithintherangeof1/5to1/2oftheCmax.第9題Theextractionrecoveryisusedtoevaluatetheextractionabilityofthesampleprocessingfromthebiosamples.Thevalidationfocusesonwhethertheanalytecouldbecompletelyextracted.第10題Theapplicationofstableisotope-labeledinternalstandardcannotonlyoffsetthematrixeffectduringmassspectrometryionization,butalsoeliminatethedifferenceinthesamplepreparationprocess.

第11題Whichoneisnotpartofthestabilitytestduringthevalidationofabioanalyticalmethod?ALong-termstoragestabilityBShort-termroomtemperaturestabilityCFreeze-thawstabilityDMobilephasestability第12題WhenusingLC-MStoanalyzebiosamples,itisnecessarytoevaluatewhethertheanalyteandtheco-eluatederivedfromthematrixcompeteforionizationattheLC-MSinterface.Whatisthisvalidationitemcalled?AAccuracyBStabilityCExtractionrecoveryDMatrixeffectAssignment第1題ThedifferencebetweentheAPCIandESIisAInAPCI,theanalyteabsorbsthelightemittedbythevacuum-ultravioletlampinthegasphaseandthenisionizedbyreleasingelectrons.

BAPCIhasnocoronadischargeneedle.CESIusescoronadischargetoionizethemobilephase.DComparedwithESI,APCIhasevaporatorandcoronadischargeneedle.第2題InLC-MS,whichreagentcannotbeaddedintothemobilephase?AAmmoniumacetateBFormicacidCAmmoniaDDisodiumphosphate第3題ESIissuitabletoanalyzethecompoundwithmediumtostrongpolarity,especiallythosethatcanformionsinthesolvent.第4題APCI

ismoresuitablefortheanalysisofioniccompounds.第5題TheAPCIionsourceisnotsuiblewhenanalyzingpeptides.第6題InLC-MS,non-volatileregentscanbeaddedintothemobilephase.第7題WhenusingLC-MStomeasurealkalinesubstances,thepHvalueofthemobilephaseshouldbelessthanpKa-2,andtheMSshouldbeworkedinthenegativeionmode.第8題IntriplequadrupoleLC-MS/MS,whichmodeshouldbeusedforthequantitativeanalysis?AProductionscanBPrecursorionscanCSelectivereactionmonitoringDNeutrallossscan第9題WhenanalyzingbiosamplesbyLC-MS,whichonecannoteliminatethematrixeffect?AChangetheionizationinterfaceBIncreasetheinjectionvolumeCOptimizethesamplepretreatmentmethodDAdjustthemobilephasecomposition第10題InLC-MS/MS,productionscanningismainlyusedforthequantitativeanalysis.第11題InLC-MS,thenegativeionmodeisusedforalkalinesubstances.

第12題Generallyspeaking,thedirectionofallparticlesincapillaryelectrophoresisisdeterminedbyAParticlesizeBParticleshapeCIonicstrengthDElectroosmoticflow

第13題TheprofileoftheelectroosmoticflowinHPCEandthatofthemobilephaseinHPLCareABothareadvection.BBotharelaminarflow.CTheformerisflatflow,andthelatterislaminarflow.DTheformerislaminarflow,andthelatterisflatflow.

第14題Inordertoimprovetheselectivityandresolutionofmicellarelectrokineticcapillarychromatography,optimizationmethodsincludeAChoosethetypeandconcentrationofmicelles.BChangethetypeofbuffer.CChangetheionicstrength.DChangethebuffercompositionandpH.

正確答案:ABCD第15題Whichfactorscouldaffecttheelectrophoreticmobilityofaprotein?ANetchargeBWeightCParticlediameterDThedifferenceinshape正確答案:ABCD第16題Whatarethefactorsaffectingelectroosmoticflowincapillaryelectrophoresis?AElectricfieldstrengthBBufferconcentrationCTemperatureDBuffertype

正確答案:ABCDAssignment第1題Whichofthefollowingisnotanadvantageofradioimmunoassay?AItcandetecttraceantigenandhapten.BItcandetecttraceantibody.CHighsensitivity.DHighspecificity.第2題Whichoneaboutthestandardforradioimmunoassayisright?AIthasthesameimmuneactivityandnoequalaffinityasthetestedsample.BIthasthesameimmuneactivityandaffinityasthetestedsample.CIthasdifferentimmuneactivityandaffinitycomparedwiththetestedsample.DIthasdifferentimmuneactivitybutsameaffinityasthetestedsample.第3題Whatarethenecessaryregentsforacompleteradioimmunoassay?ASpecificantigen,labeledantibodyBLabeledantigen,standard,specificantibody.CSpecificantibody.DLabeledantigen,

standard.第4題Whichoneisthecorrectdescriptionaboutthedisadvantegeofradioimmunoassay?APoorsensitivityBLowspecificityCPoorrepeatabilityDRadioactivecontaminationofnuclides第5題Basedonwhatcouldenzymeimmunoassaybedividedintohomogeneousandheterogeneoustechniques?AAntigeniccharacteristics.BAntibodycharacteristics.CWhetheritisnecessarytoseparatebindingandfreemarkersafterantigen-antibodyreaction.DStabilityofenzyme.第6題Whichofthefollowingdescriptionoffluorescentmarkersfortime-resolvedfluorescenceimmunoassayarecorrect?AThemarkerisinstable.

BLanthanidechelatecouldbeusedasamarker.

CThefluorescencedecaytimeofsomeproteinsinbiosamplesin1-1000microseconds.

DItcaneffectivelyeliminatetheinterferenceofnon-specificbackgroundfluorescence.正確答案:BD第7題IntermsoftheadvantagesofCEIA,whichoneisnotcorrect?ASomeproteincomponentscouldbeseparatedaccordingtotheircharge,andthenreactedwithantibody.BCEIAneedsmallamountofthesample.

CThefreeandbindingformsofimmunecomplexescanbeobserveddirectly.DItcannotsolvethefalsepositiveproblemcausedbycrossreactioninimmunereaction.第8題Capillaryelectrophoresis-basedimmunoassayisabbreviatedasACIEFBCEIACCITPDMECC第9題Amongthefollowingdetectionmethods,whichcouldbeusedforthecapillaryelectrophoresis-basedimmunoassay?AUVdetection.BLaser-inducedfluorescencedetection.CParticle

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論